Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation

查看全文 作　　者：Li [1]YANG;Li-ping [1]SHI;Hai-jun [2]CHEN;Xian-kun [1]TONG;Gui-feng [1]WANG;Yang-ming [2]ZHANG;Wen-long [2]WANG;Chun-lan [1]FENG;Pei-lan [1]HE;Feng-hua [1]ZHU;You-hua [3]HAO;Bao-ju [3]WANG;Dong-liang [3]YANG;Wei [1]TANG;Fa-jun [2]NAN;Jian-ping [1]ZUO

机构地区：[1]Laboratory of Immunopharmacology;[2]Chinese National Center for Drug Screening, State Key Laboratory of Drug Research, Shang- hai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China;[3]Tongji Hospital of TonEji Medical College, Wuhan 430030, China

出　　处：《Acta Pharmacologica Sinica》索引2014年第35卷第3期,共9页

关键词：核苷类化合物病毒复制乙型肝炎 RNA 基因组 WESTERN印迹琼脂糖凝胶电泳法 HEPG2

相关文献

参考文献（23）
引证文献（15）
耦合文献（0）

参考文献(23)

引证文献(15)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation

参考文献(23)

引证文献(15)

用户提示